<DOC>
	<DOCNO>NCT00891501</DOCNO>
	<brief_summary>This study conduct ass whether implant autologous , culture-expanded , mesenchymal stem cell obtain bone marrow patient early osteoarthritis , cartilage defect cartilage underlie bone cartilage ( osteochondral ) defect joint effective treatment condition alleviation patient symptom .</brief_summary>
	<brief_title>The Use Autologous Bone Marrow Mesenchymal Stem Cells Treatment Articular Cartilage Defects</brief_title>
	<detailed_description>All procedure carry obtain inform write consent patient . Bone marrow aspirate iliac crest ( hip bone ) patient osteochondral defect intraoperatively complete sterile , aseptic condition proper anaesthesia ( general , local ) . The bone marrow aspirate place tube transfer aseptic condition Tissue Culture Unit Biochemistry Department Cairo University School Medicine process bone marrow mesenchymal stem cell isolate grown culture 2-3 week . After time interval , cell reprocess cell pellet obtain . Implantation cell pellet osteochondral defect joint embed proper scaffold perform followed subsequent defect coverage autologous periosteal flap obtain proximal tibia seal defect maintain cell pellet place . The patient assess clinically score system preoperatively well 6 12 month postoperatively assess relief symptom joint function . Radiological assessment ( X-rays MRIs ) affect joint perform time point aforementioned assess integrity form cartilage . Second look arthroscopy biopsy also perform histologically assess repair tissue grade via arthroscopic grading system accord International Cartilage Repair Society guideline .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Cartilage Diseases</mesh_term>
	<mesh_term>Osteochondrosis</mesh_term>
	<criteria>Active patient ( 15 55 year ) . An isolated osteochondral defect ( i.e. , joint otherwise healthy articular surface cartilage oppose surface grade 1 2 Outerbridge . A defect 1 4 cm2 ( 16 cm2 ) . Patients young 15 year old 55 year . Diffuse advance articular cartilage degeneration joint Axial malalignment , meniscal pathology , ligamentous instability RELATIVE contraindication deal primarily either concomitantly transplantation 1 2 stage procedure . Refusal patient address condition presence cartilage lesion criterion exclusion study . Kissing lesion ( i.e. , oppose surface joint ) . Existing infection around joint &amp; lesion infectious oncologic etiology . Debilitated patient . Immunocompromised patient . Patients autoimmune disorder &amp; systemic inflammatory disease . Preoperative poor neurological vascular status affect limb . Specific contraindication include use tobacco medication may impair cell proliferation , NSAIDs immunosuppressive drug . Patients must nicotinefree ( stop smoking ) prior procedure , study show oxidative effect smoke impairs cell function subsequent healing .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>autologous bone marrow mesenchymal stem cell</keyword>
	<keyword>cartilage repair</keyword>
	<keyword>osteoarthritis</keyword>
	<keyword>osteochondral defect</keyword>
</DOC>